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We have confirmed heterogenity in C F  using a different combination of primary 
clinical variables than those used in previous studies. Subgroupings of individuals 
with similar levels of sweat chloride were independent of the clustering based on 
level of pancreatic enzyme supplementation and degree of pulmonary involve- 
ment. Data from families with multiple CF children are consistent with the 
hypothesis that the genetic etiology of C F  involves two or more genes that modify 
the expression of the primary gene defect. 
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INTRODUCTION 
Cystic fibrosis of the pancreas (CF) is a common genetic disorder that often leads 
to serious complications and death at an early age. The presenting symptoms of the 
disease are usually related to malabsorption and/or pulmonary involvement. The 
primary clinical sign that confirms a diagnosis of cystic fibrosis is the elevation of 
sodium and chloride ions in sweat [Wood et al, 19761. It is well known that there is con- 
siderable heterogeneity in the manifestation of CF. Before the sweat test was 
developed, cystic fibrosis patients were frequently undiagnosed until after the disease 
process had already done extensive damage that could have been lessened if treatment 
had followed an earlier diagnosis. For those diagnosed as having CF, there is also con- 
siderable variation in the severity of the disease. The mildest extreme is represented by 
those who are not diagnosed until middle age [Scully et al, 19771. 
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It is widely accepted that cystic fibrosis is a monogenetically determined disease, 
but the specific location of the gene or gene products that cause the disease have not 
been identified. Individuals with cystic fibrosis are usually born to normal parents, 
although they may have relatives who are affected. Equal incidence in the two sexes and 
a segregation of Yi affected children of unaffected parents in a number of early studies 
[Anderson and Hodges, 1946; Danks et al, 19651 argue for an autosomal recessive gene 
as the cause of the disease. Despite these convincing data, the high frequency of CF in 
the Caucasian population and the great variability in disease expression among and 
within families has suggested to some workers that one or more dominant genes may be 
involved [Baumann, 1958; Schaap and Cohen, 19761. It has been suggested that 
heterogeneity in the severity of the disease may be explained by variability in the expres- 
sion and penetrance of the gene for cystic fibrosis [Frydman, 1979; Danes and Bearn, 
19691. Schaap and Cohen [1976] give a comprehensive review of the genetics of CF and 
suggest further that the high incidence of this disease can be explained by an epistatic 
interaction between dominant alleles at each of two loci. Definitive studies to decide 
among alternative genetic models to explain the inconsistencies of the observations 
with a single autosomal recessive causation have yet to be carried out. 
The purpose of the studies reported in this paper was to identify those measures of 
CF patients that discriminate subclasses of the disease. These studies were conducted on 
data collected from patients seen at the Mott Children’s Hospital at the University of 
Michigan. We identified four distinct subgroups of patients who vary in the severity of 
TABLE I. Summarv of Variables Studied 
Variablea 
Sweat chloride 























































































a All variables except the sweat value were recorded at the University of Michigan CF clinic at the last 
exam. All sweat values are those at age of diagnosis either at the University of Michigan (54 cases) or 
by a reputable CF laboratory (29 cases). 
Equivalent number of Viokase pills per day (explanation in test). 
CF Heterogeneity 181 
their disease. The distribution of these groups among affected sibs suggest needed stud- 
ies to determine the causes and control of the expression of the traits we have examined. 
The Sample Studied 
Between 1970 and 1979 we examined a sample of 104 patients at the Mott 
Children’s Hospital of the University of Michigan. Most of the patients are from 
Southeast Michigan, which includes the Detroit area. However, the sample also in- 
cludes individuals from within a 500 mile radius, since many patients were referred to 
the cystic fibrosis center at the Mott Hospital for treatment. Fifty-four patients were 
diagnosed at the University of Michigan CF Clinic; the remaining 50 were diagnosed 
before referral to the Mott Children’s Hospital. 
There are 53 female patients and 51  male patients in the sample distributed 
among 73 sibships (see Table VII). The diagnosis of CF was confirmed in all cases by 
sweat sodium level when diagnosed at the University of Michigan or by sweat sodium 
or chloride when diagnosed elsewhere. The average age of diagnosis was 2.4 yr. The 
second CF child in the multiplex families studied (N = 16) also had an average age of 
diagnosis of 2.4 yr. The range in age of diagnosis was from birth to 16 yr, with 75% of 
the patients diagnosed by 7 yr. Only six patients were diagnosed after 10 yr. 
The patients include 72 Caucasians, three Blacks, one Mexican, and two of mixed 
parentage. Information is limited on the nationality of the sample, but we know that 
there are a number of patients with German ancestry. Cystic fibrosis is considered to be 
a disease that is predominantly confined to the Caucasian race [Cystic Fibrosis Founda- 
tion, 19771 and our data support this. 
MATERIALS AND METHODS 
Data Collection Procedures 
All clinical variables were collected at the University of Michigan clinic. The age 
of examination ranged from 1 to 33 yr (X = 9.6 yr). Data collection involved a careful 
review of the physicians’ clinic reports, with the information on each patient being 
transcribed to a standardized form. The review was undertaken either by physicians or 
assistants under their direct supervision. Clinical data included ratings of the severity of 
pulmonary involvement, including cough, rales, clubbing, chest shape, and chest film 
findings. The measures of gastrointestinal involvement included digestive enzyme dose 
and general physical condition. In addition to sweat test results, SGPT, SGOT, alkaline 
phosphatase, albumin, and total protein were considered. Although all individuals 
studied were diagnosed by the sweat test, values were available from the referring 
physician on only 29 of the 50 patients who were not diagnosed at the University of 
Michigan clinic. The data available also included information about the disease status 
of all sibs. 
The Variables Studied 
The array of variables studied was selected because they are generally considered 
to reflect the clinical manifestations of CF. All but sweat sodium were evaluated at the 
time of clinical examination at the University of Michigan CF clinic. The scale of 
measurement and the mean and standard deviation for each is given in Table I. The in- 
dicators of pulmonary damage were discrete categories ranging from least (grade 1) to 
greatest deviation from normality (3 or 4). Enzyme supplementation was Viokase 
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powder (N = 14), Viokase pills (N =61), Cotazyme powder (N = 2), Cotazyme capsules 
(N= 14), Pancrease capsules (N=2), or not recorded (N=2). Nine patients were not 
receiving enzyme supplementation when examined. Standard enzyme dose was ex- 
pressed in terms of equivalent number of Viokase pills per day for this study. These 
equivalents were arrived at by multiplying the number of Pancrease pills by 4, 
Cotazyme powder packets by 2, and teaspoons of Viokase powder by 7, one Cotazyme 
capsule being the equivalent of one Viokase pill. Liver size was evaluated (by palpation) 
in cm below the costal margin. Laboratory data were obtained from a serum sample 
collected at the most recent date of examination. 
The deviation of an individual's age at exam from the average of all exam ages for 
those who share his grade of pulmonary involvement (Table I) was taken as an age- 
corrected measure of pulmonary severity. This was done separately for each of the five 
measures of pulmonary function. Individuals with positive deviations, regardless of 
their severity rating for the pulmonary variable, are assumed to be experiencing a less 
severe course of the disease than those who deviate negatively. A statistically significant 
positive correlation was observed between age of diagnosis and each of these variables 
(eg, 0.51 with exam age deviation for a given grade of x-ray finding). These age cor- 
rected measures of severity were then used in all analyses, rather than contrasting the 
severity rating directly. 
Statistical Procedures 
The objective of the statistical analyses was to identify those variables that 
characterize homogeneous subgroups of CF patients. All analyses reported here were 
carried out using the Michigan Interactive Data Analysis System (MIDAS) on the 
University's Amdahl470-V8. Contrasts between patients diagnosed at the University of 
Michigan and those diagnosed at other institutions were made for each of the analyses 
reported below, to identify any possible ascertainment biases that might exist in the 
study sample. 
A description of the data was followed by an investigation of the effects of dif- 
ferences in age and sex on each of the continuously varying measures of sweat, birth 
weight, pulmonary severity, gastrointestinal and laboratory variables. Analyses of the 
matrix of correlations among these age- and sex-adjusted variables were performed to 
reduce the dimensionality of the data set. In this way we were able to identify the most 
parsimonious subset of variables on which to base identification of phenotypic 
heterogeneity. This was followed by a cluster analysis to identify subclasses of patients. 
Duran and Ode11 [1974], and Sneath and Sokal [1973], review the principles of cluster 
analysis. It is a nonstatistical technique to explore systematically the information con- 
tained in a multivariate set of data on the similarities between individuals. As such it is a 
technique for generating hypotheses rather than for testing hypotheses. A number of 
combinations of distance measures and clustering algorithms were considered. The 
greatest discrimination between subgroups of patients and the highest cophenetic cor- 
relation was given by the minimum variance algorithm [Ward, 19631 with nearly iden- 
tical assignments of individuals when either the Euclidean or the correlation measure of 
distance was employed. The correlation measure used in this study places in the same 
group individuals who have the highest correlation for the variables studied while the 
correlations between pairs in different groups is minimized. Principle component 
analyses were then employed to generate the linear functions that gave the greatest 
discrimination among groups. 
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RESULTS 
Analyses of the effects of age, sex, and place of diagnosis were carried out on the 
sweat, birth weight, pulmonary, gastrointestinal and laboratory variables given in 
Table I. In addition, the exam age at which a patient had achieved a given grade for 
each of the five measures of pulmonary severity was considered. There were no 
statistically significant differences in mean levels for any of the 15 continuous 
variables, or in frequencies of the discrete pulmonary grades, between those diagnosed 
at the University of Michigan and those diagnosed elsewhere. As might be expected, 
there was a statistically significant (P = 0.05) relationship between age and a number 
of the measures considered. These findings are summarized in Table 11. Sweat levels in- 
creased 1.26 mEq/liter for each year increase in the patient’s age at diagnosis. 
Pulmonary severity grades were predictive of the age when the patient was evaluated. 
On the average, each grade increase in severity was associated with 1.4 to 6.7 yr increase 
in the patient’s age at examination. Rales and chest film findings progressed most 
rapidly. The number of years to change to one more severe grade was greatest for chest 
shape, but it should be pointed out that chest shape is only a three-grade scale, while the 
other pulmonary variables are four-grade scales. Again, the contrast of regressions be- 
tween patients diagnosed at the University of Michigan and those diagnosed elsewhere 
was not stastistically significant at the 0.10 level of probability for any of the variables 
considered. 
The male patients were 72 gm heavier at birth than females. The male-female 
comparisons of disease symptoms were not statistically significant for any one of the 
other 14 continuous variables considered. However, inspection of the differences 
revealed a trend. For every measure of pulmonary severity, females were younger than 
males for a given grade of involvement. This concordance might be expected because 
the five ratings are highly correlated (see below), either because the physician failed to 
grade indepently each of the symptoms or because they all are measuring a common 
biological phenomenon. In such a case, one is interested in considering the vector of 
exam age deviations to determine if sex is affecting the process being measured. The 
multivariate contrast [Kramer, 19721 between sexes was significant at the 0.03 level of 
probability. The age at which females achieved a given grade of severity (Table 111) 
TABLE 11. Summary of Statistically Significant 
Relationships Involving Age of Patient 
TABLE 111. The Age Difference 
Between Males and Females at Which a 
Given Severity Grade Was Achieved 
Linear regression 
Dependent coefficient Male-female 
variable Predictor (* SE) age difference 
Variable (years) 
Cough grade 1.2 
Rales grade 1.4 
Chest shape grade 1.2 
Chest film grade 1.9 
Sweat Age of diagnosis 1.26(* 0.45)a 
Exam age Cough grade 2.40(+ 0.50)b 
Rales grade 1.42(+ 0.56)a 
Clubbing grade 2.31(% 0.54)b 
Chest shape grade 6.73(+ 0.57)b 
Chest film grade 1.43(& 0.56)a 
a Significantly different from zero at the 0.01 level of 
probability. 
probability. 
Clubbing grade 0.9 
Average 1.32 
Significantly different from zero at the 0.001 level of 
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ranged from 1.2 to 2 yr younger than males (average difference equals 1.32 yr). A 
similar effect was apparent with sweat level adjusted for age of diagnosis, and for stan- 
dardized enzyme dose, liver size, SGPT, SGOT, alkaline phosphatase, total protein, 
and albumin, each adjusted for exam age. These data support the observation that 
females are more severely affected by the CF gene [Kramm et al, 19611. 
We next turned to evaluating which variables were of greatest value in 
discriminating among subgroups of patients. The correlation matrix for the 15 con- 
tinuously varying measures given in Table IV was investigated for this purpose. The 
male and female matrices were very similar. Within the pooled matrix certain patterns 
emerge. The age of the patient when his grade of pulmonary severity was recorded was 
not independently distributed among the five measures considered. The correlation 
ranged from 0.92 between age/cough grade and age/clubbing grade to 0.99 for ages 
associated with grade of chest shape and rales. All other correlations were small and 
not statistically significant at the 0.01 level of probability except for the relationship 
between SGOT and SGPT (0.87) and between total protein and enzyme dose (0.55). 
A principal component analysis using the correlation matrix [Kshirsagar, 19791 
showed that the dependence structure in these data may be reduced to three linear func- 
tions, which explained 92% of the total variability represented by the 15 variables con- 
sidered. Sweat, enzyme dose, and the pulmonary variables contributed the greatest to 
determining total variability. Because all measures were not taken on every patient, the 
search for the most parsimonious subset of variables must also include the considera- 
tion of sample size. Seventy-seven patients were measured for sweat, enzyme dose, and 
the five measures of pulmonary involvement. Again, three linear functions of these 
measures on the larger sample accounted for 89% of the total variability. Ninety-six 
percent of the variability in the five measures of pulmonary function was explained by 
one linear function, which weighted each variable nearly identically (coefficients 
ranged from 0.398 to 0.414). This result reflects the high correlations among the exam 
age measures of pulmonary severity discussed above and justified the selection of only 
one of this set of severity measures for further consideration. 
The combination of sweat, enzyme dose, and exam age adjusted for grade of 
x-ray findings was used next in a cluster analysis to identify homogeneous subgroups. 
Age variability was removed from sweat and enzyme dose and each variable was stan- 
dardized by subtracting the mean and dividing by the standard deviation prior to con- 
ducting the cluster analysis. The resulting clusters are presented in Figure 1. The cluster 
diagram is a nonstatistical statement about the similarities between individuals. Those 
cases that are joined at small distances are more similar for the traits considered than 
those connected at larger distances. Four major clusters of patients are suggested by the 
distance values among subsets. The average distance between pairs of patients (one 
from cluster 2 and the second from cluster 3 or 4) is at least 40 times as large as the 
average distance between those individuals placed within clusters 2, 3, and 4. The 
average distance between clusters 3 and 4 is approximately ten times greater than the 
distance between pairs of individuals in either cluster. Individuals within these three 
clusters are on average at least 4.5 (6.811.5) and at most 6.8 times (6.8A.O) more 
similar than those 29 individuals assigned to cluster 1. 
A statistical summary of the unstandardized variables used to establish these 
hypothesized groupings is given in Table V. The mean values for sweat, enzyme dose, 
and exam age adjusted for grade of x-ray finding typify the four clusters. Sweat and en- 
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1 2 3 4 CLUSTER 
GROUP 
Cophentic correlation : 0.7756 
Fig. 1. A cluster analysis using the minimum variance algorithm and the correlation measure of distance. 
significantly heterogeneous for variables not included in the cluster analysis. We car- 
ried out the cluster analysis on each sex to be certain that the analysis was not sorting 
out a sex difference. The data presented in Table VI also indicate that the clustering is 
independent of the sex of the patient. 
Figure 2 is a graphic representation of the standardized data being clustered. For 
example, the centroid for cluster 1 in three-dimensional space deviates high for sweat, 
low for enzyme dose, and high for the exam age associated with an individual's grade of 
chest film severity. Sweat level is significantly higher in clusters 1 and 2 than in clusters 
3 and 4, while enzyme dose in clusters 1 and 3 is significantly lower than in clusters 2 
and 4. Although the test of heterogeneity among all clusters for exam age/chest film 
grade was not significant (Table V), the pooled contrast of 1 and 3 versus 2 and 4 was 
significant at the 0.05 level of probability. 
The relationship between the variables in the sample of patients that discriminate 
the four clusters are apparent in the three principal components. They are 
X, = 0.69 (sweat) + 0.49 (dose) + 0.53 (exam age), 
X, = 0.00 (sweat) - 0.73 (dose) + 0.68 (exam age), 
and X3 = -0.72 (sweat) + 0.47 (dose) + 0.51 (exam age). 
These orthogonal functions account for 40, 32, and 28%, respectively, of the total 
variability represented by the three variables. The first is a general measure of the 
degree of involvement of the three, while the second and third are functions that con- 
trast dose with exam age (A2), and sweat with dose and exam age (A3). The bivariate scat- 
ter of X2 and As for the 77 patients (Fig. 3) suggests that these two functions discriminate 






















































































































































































































































































































































































































































































































































































































































































































TABLE VI. Distribution of Enzyme Supplementation, Source of Sweat Test, and Pulmonary 
Severity Grades Among Clusters 
Clusters 
1 2 3 4 







20 7 10 11 0.66 
9 I 7 6 
18 7 11 13 0.50 
11 I 6 4 
Pulmonary grade 
Cough 1-2 23 9 10 12 0.19 
3-4 6 5 7 5 
Rales 1-2 25 9 10 15 0.14 
2-4 3 4 6 2 
Chest shape 1 16 5 4 9 0.14 
2 5 1 4 5 
3 3 5 4 2 
Chest film 1-2 23 8 9 14 0.19 
3-4 6 6 7 3 
Clubbing 1-2 20 8 9 9 0.51 
3-4 9 5 8 8 
Abdominal 1 17 7 8 11 0.29 
muscle 2 4 1 3 0 
3 4 3 0 4 
Sex M 17 8 9 7 0.70 
F 12 6 8 11 
a Contingency chi-square. 
University of Michigan. 
Figure 1. The third component separates the patients with high sweat from those with 
lower sweat, while the second separates those who are taking low doses of enzyme and 
are older for their chest film grade from those who are taking a higher enzyme dose and 
are younger for their chest film grade. Data presented in Table VI argue that the 
clusters are not significantly different for the distribution of patients among sex, source 
of sweat test, source of enzyme supplementation, or severity grade for any one of the 
pulmonary measures of severity. 
To investigate the distribution of the four groups of patients among full sibs in 
families, Table VII was constructed. Of the 11 families with at least 2 sibs with CF, 9 
segregated in one of only 3 different ways. From Table VII it can be seen that families 
28,85, and 86 all segregate between groups 1 and 2, families 6, 18, and 39 segregate be- 
tween groups 1 and 3, and families 38, 54, and 84 segregate between groups 3 and 4. 
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Fig. 2. 
diagnosis. 
The distribution of the exam age/chest film and sweat and enzyme dose adjusted for age of 
The hypothesis of random distribution of the four types among families is rejected at 
the 0.05 level of probability. High sweat values aggregate in families 28, 85,  and 86, 
while low values aggregate in families 38, 54, and 84. Within these two groups of 
families the same relationship between enzyme dose and exam age separates cluster 1 
from cluster 2 as separates 3 from 4. A third set of families (6, 18, and 39) have an ag- 
gregation of CF children receiving lower than average enzyme supplementation and 
greater than average exam ages when x-rayed. Children within these families vary 
markedly for sweat level (clusters 1 and 3). These data suggest that in families with 
sweat level heterogeneity the enzyme dose and exam age are homogeneous among 
children. In contrast, those siblings with relatively homogeneous sweat levels consist of 
children that vary greatly for the level of enzyme supplementation and age when the 
x-ray was evaluated. 
A segregation analysis was carried out to test the fit of a single-locus, recessive 
genetic model to the distribution of CF within sibships. This analysis followed the a 
priori method of Bernstein [1925] to correct for ascertainment of sibships through an 
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Fig. 3.  The distribution of the second (A,) and third (A,) principal components. Arrows point to in- 
dividuals who are misclassified by the principal components. The direction of the arrow indicates the group 
assigned by the cluster analysis summarized in Figure 1. 
sis was not rejected by these data (x’ = 2.45, 1 df). The chi-square for heterogeneity of 
the segregation parameter among families of different sizes was 4.5570 (6 df), not sig- 
nificant at the 0.10 level of probability. This result, which documents that these data 
are not inconsistent with a single-locus recessive inheritance model, may be compared 
with the segregation analysis performed by Danks et a1 [ 19651. Danks et a1 rejected the 
recessive inheritance model when “probable” cases were excluded from the analysis. 
However, when “probable” cases were included, the results were very compatible with 
recessive inheritance. 
DISCUSSION 
The characteristics of the 104 patients examined in this study are similar to those 
of other groups of cystic fibrosis patients [Nelson, 1969; Shwachman, 19721. All pa- 
tients who have had sweat tests have sweat levels above the 60 mEq/liter level, which in- 
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TABLE VII. Distribution of Hypothesized Phenotypes Among 






















TABLE VIII. A Segregation Analysis Based on a Single Locus Model of Recessive 
Inheritance 












affecteds affecteds Variance 
(R,) (NS [E(RS)I) [V(RS)I 
33 32.00 0.1224 
26 23.35 0.2629 
19 16.09 0.4200 
6 4.92 0.5917 
11 9.12 0.7759 
3 4.04 0.9702 
1 2.22 0.1723 
dicates a diagnosis of CF. Most were diagnosed during childhood. There was a variety 
of levels of severity for the pulmonary variables and also variation in the amount of 
pancreatic supplementation required. The patients studied are considered to be 
representative of CF. 
The differences between males and females in the age at which each achieved a 
given grade of severity (Table 111) indicates that females tend to be more severely af- 
fected by the CF gene than males. On the average females achieved a given grade of 
severity 1.32 yr ahead of males. Furthermore, the females’ age of diagnosis (2.2 yr) was 
younger than that of males (2.6 yr). The implication is that females may be 
characteristically more severely affected by the CF gene than males, a finding alluded 
to in other studies [Kramm et al, 1961; Blacharsh, 19771. Studies that suggest an excess 
of surviving males [Shwachman and Kulczycki, 1958; Danks et al, 19651 provide fur- 
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ther evidence of a sex difference in severity. The reasons for this finding are at  present 
unknown. 
A correlation matrix is presented in Table IV, in which all of the primary vari- 
ables examined in this study are compared. It is clear that the severity of pancreatic in- 
volvement is not correlated with the severity of pulmonary involvement, a finding that 
has been indicated by other studies [Shwachman et al, 1956, 19651. It may be further 
noted from the correlation matrix that all of the measures of pulmonary severity are 
highly correlated with one another, which is not unexpected since each is probably a 
measure of the same phenomenon. 
The four groups of patients identified by the cluster analysis clearly indicate that 
this is a heterogeneous disease. The heterogeneity identified here is based on three 
variables, sweat level, enzyme dosage, and examination age for chest x-ray class. The 
shape of the cluster diagram (Fig. 1) and the mean values of the cluster variables for 
each cluster (Table V) argue that there are four quite distinct groups of patients in this 
data set. The nature of the clustering and the distance between clusters defined by the 
mean values are consistent with the coefficients of the second (A,) and third (A,) prin- 
cipal components (Fig. 3). It is highly relevant for the study of CF (and other diseases 
where phenotypic heterogeneity is an issue) that investigators realize that although the 
variables of interest may not be correlated over an entire data set (Table IV) documents 
that the three variables used here are uncorrelated), important information about the 
variability of patients may reside in the multivariate dimensions of the data set. The CF 
analysis presented here serves as an example of such a possibility. 
Numerous other studies have appeared that review heterogeneity in CF, including 
heterogeneity in sweat levels, pancreatic involvement, and pulmonary involvement. 
Gaskin et al, [1980] discuss heterogeneity in a group of CF patients, all diagnosed by 
sweat electrolyte levels. These patients were divided into two groups on the basis of 
pancreatic involvement, those with and those without steatorrhea. It was found that 
those without any apparent pancreatic damage have better pulmonary function, while 
those with some pancreatic damage have poorer pulmonary function. This finding was 
confirmed in the present study. In each of the classes where the enzyme dose is low, in- 
dicting a milder pancreatic disease, the exam age adjusted for age differences in grade 
of chest film abnormality is high, indicating a milder degree of involvement of the 
pulmonary disease. It should also be pointed out that, even within the group of in- 
dividuals whose pulmonary function is only mildly affected for age (group 3), the 
pulmonary involvement may still be severe enough to cause death. Because the 
pulmonary measure of severity reflects the exam age at which a level of damage was 
achieved, such a finding simply indicates that death due to respiratory failure will occur 
at an older age in this group of patients. The study by Oppenheimer [1972] reviews 
autopsied cases of patients dying of complications of cystic fibrosis. He notes that in 8 
of 99 cases there was no pancreatic lesion, even in the older cases. These data suggest 
that the information contributed by sweat level to the discrimination among children 
(cluster 1 and 2 different from 3 and 4) is independent of the relationship between pan- 
creatic damage and pulmonary function that separates clusters 1 and 3 from 2 and 4. 
Other studies have detected heterogeneity based on characteristics that are com- 
pletely independent from those considered in the current study. These include the 
studies by Danes et al, who have investigated heterogeneity in cell culture status in 
groups of CF patients. Danes and Bearn [1969] and Danes and Flensborg [1971] recog- 
nized differences in cell culture types between different groups of patients. When the 
CF Heterogeneity 193 
different cell culture classes were then compared to the level of clinical severity, it was 
shown that one of the cell culture classes, the ametachromatic class, or class 111, is a 
group with an earlier age of diagnosis [Danes and Flensborg, 19711, a poorer progno- 
sis, and more severe involvement [Bearn and Danes, 1978; Danes, 19721. 
Principal components analysis describes the relationships between variables that 
discriminate the groups identified by the cluster analysis. When the second and third 
principal components are scattered against one another (Fig. 3) it can be seen that each 
of the cluster groups is located primarily in one quadrant of the scatter. Only 15 of the 
77 cases (19.5%) were misclassified when X, and X3 were used as discriminators. Thus, 
these functions and the associated cutpoints of X, = -0.27 and X3 = 0.12 may be ex- 
pected to correctly classify unstudied patients into the groups identified by the cluster 
analysis over 80% of the time. Prospective studies to  evaluate these functions are in 
progress by our group. 
The four “phenotypes” identified by the cluster analysis do not appear to be 
segregating randomly within families. Although the numbers are small, two kinds of 
familial aggregation of clusters are suggested by these data. In the first, all CF siblings 
had either higher or lower than average sweat levels and in the second the siblings share 
levels of enzyme dose and pulmonary involvement. The independent aggregation of 
these predictors of severity is consistent with a familial basis, either genetic or en- 
vironmental in origin, for the heterogeneity among the clusterings of CF patients. Fur- 
thermore, the independence of the familial aggregation of these two phenotypes is con- 
sistent with the hypothesis that the cause of cystic fibrosis may involve two or more 
genes that modify the control of the expression and penetrance of a single cystic fibrosis 
gene. A study in progress of a larger number of families with at least two CF children 
will provide data for the comparison of alternative models for the distribution of the 
phenotypes suggested by the cluster analysis presented here. 
To  investigate the course of disease in the subgroups suggested by this study a 
preliminary followup was carried out. These results are presented in Table IX. It is ap- 
parent that group 2, which has the more severe combination of values for the 
discriminating variables, also had an earlier age of diagnosis, a higher death rate since 
the last examination, an earlier age of death, and that they died more recently after the 
last examination than did those in group 3, a less severely affected group of patients. 
The analyses carried out in this study may be applied to achieve a better 
understanding of CF. Having identified these different groups of patients will enable 
one to prognosticate on the basis of only a small number of variables. These findings 
may also be used to relate pathogenetically the various aspects of the disease; they pro- 
vide clues for the development of a genetic model that can explain all of the manifesta- 
tions of the disease. 
CONCLUSIONS 
We have confirmed the heterogeneity in CF based on a group of the primary 
clinical variables. However, the present study has used a different combination of 
variables to define groupings than those used in previous studies. Further study will be 
needed to establish whether these variables are the most efficient predicators of the 
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